Moderna Inc

NASDAQ:MRNA   12:24:07 AM EDT
176.86
+0.46 (+0.26%)
Products

FDA Says It Has Determined That Certain Moderna Covid-19 Vaccine, Bivalent Lots Manufactured At Catalent Indiana Llc Are Suitable For Use And Meet Eua Standard

Published: 09/27/2022 09:46 GMT
Moderna Inc (MRNA) - FDA - Determined That Certain Moderna Covid-19 Vaccine, Bivalent Lots Manufactured at Catalent Indiana Llc Are Suitable for Use and Meet Eua Standard.